Exploring the comorbidity mechanisms of ITGB2 in rheumatoid arthritis and membranous nephropathy through integrated

Wenlong Cao1, Yuqin Wang2, Jing Xiong1

  • 1Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Renal Failure
|July 23, 2025
PubMed
Abstract

Insights

Rheumatoid arthritis (RA) and membranous nephropathy (MN) share a common pathogenic gene, ITGB2. This gene influences macrophage polarization and B cell maturation, suggesting potential therapeutic targets for both diseases.

Area of Science:

  • Immunology
  • Nephrology
  • Bioinformatics

Background:

  • Rheumatoid arthritis (RA) patients frequently develop comorbid renal diseases, most commonly membranous nephropathy (MN).
  • Understanding the shared pathogenesis between RA and MN is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the common molecular mechanisms underlying rheumatoid arthritis and membranous nephropathy.
  • To identify shared pathogenic genes and pathways using integrated bioinformatics analysis.

Main Methods:

  • Acquired and analyzed bulk and single-cell RNA sequencing data from public databases.
  • Identified differentially expressed genes (DEGs), hub genes, and immune cell infiltration.
  • Utilized pseudotime and cell communication analyses to explore gene function and interactions.
  • Screened for potential drugs targeting identified key genes.

Main Results:

  • Identified 66 common upregulated DEGs linked to leukocyte migration and chemokine signaling.
  • ITGB2 was confirmed as a shared pathogenic gene in RA and MN.
  • ITGB2 expression increased during M0 to M1 macrophage differentiation, enhancing BAFF signaling between macrophages and B cells.
  • Potential drugs targeting ITGB2, such as LY-294002 and CP466722, were identified.

Conclusions:

  • ITGB2 is a key shared pathogenic gene in RA and MN.
  • ITGB2 may drive M1 macrophage polarization and B cell differentiation via BAFF signaling.
  • Targeting ITGB2 presents a potential therapeutic strategy for both RA and MN.

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
14.3K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.3K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
2.8K